Sort
64,565 grants matching “drug discovery”
Data Organizing Core
$1,018,328Tudor I Oprea · University Of New Mexico Health Scis Ctr · U54 · FY2015 · CA
Validation and early development of a blood-based rapid diagnostic test for sepsis endotypes
$1,017,950Timothy E Sweeney · Inflammatix, Inc. · R44 · FY2022 · GM
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
$1,017,618Michael-Christopher Keogh · Epicypher, Inc. · R44 · FY2025 · HG
Center for Interventional Oncology
$1,017,591Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2009 · CA
Research Capacity Core
$1,017,215Song Gao · Texas Southern University · U54 · FY2025 · MD
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,017,150Harry Bernard Greenberg · Stanford University · UL1 · FY2011 · RR
Open Drug Discovery Center for Alzheimer's Disease
$1,017,042Allan I Levey · Emory University · U54 · FY2020 · AG
Targeting Epigenetic Circuits in B-Cell Lymphomas
$1,017,000Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2018 · CA
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
$1,017,000Ronald N. Harty · Fox Chase Chemical Diversity Center, Inc · R42 · FY2021 · AI
Console and Probe Upgrade for a 700 MHz NMR Spectrometer
$1,016,907Amy H Andreotti · Iowa State University · S10 · FY2022 · OD
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
$1,016,761Mayland F Chang · University Of Notre Dame · R01 · FY2012 · AI
A Quantitative Systems Pharmacology Software Platform for Biologics: reduce costs and accelerate development of innovative biotherapeutics
$1,016,648Joshua Apgar · Applied Biomath, Llc · R44 · FY2017 · GM
Biomarker Signatures of TB Infection in Young Children With and Without HIV
$1,016,533Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads
$1,016,453John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2022 · GM
REMIT (Rescue Mitochondrial Therapeutics): Unlocking Broad-Spectrum Mitochondrial Rescuers
$1,016,229Ethan Perlstein · Perlara, Pbc · R44 · FY2025 · GM
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,016,184Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Obstetric Pharmacology Research Units Network Center at UTMB-Galveston
$1,016,161Gary D Hankins · University Of Texas Med Br Galveston · U10 · FY2014 · HD
Vanderbilt Genome Electronic Records Project
$1,016,001Dan M Roden · Vanderbilt University · U01 · FY2013 · HG
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
$1,015,871Frank W. Marcoux · Leukogene Therapeutics, Inc. · R42 · FY2019 · CA
Exploration, conservation, & development of marine biodiversity in Fiji and the S
$1,015,562Mark E Hay · Georgia Institute Of Technology · U19 · FY2015 · TW
Epilepsy Research Program
$1,015,488John R Huguenard · Stanford University · P01 · FY2008 · NS
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
$1,015,449Ronald N. Harty · Fox Chase Chemical Diversity Center, Inc · R42 · FY2022 · AI
Topical Microbicides for Prevention of STDs/HIV
$1,015,369Magee-Women'S Res Inst And Foundation · P01 · FY2003 · AI
Impedance Threshold Value for Improving Standard CPR
$1,014,996Keith G Lurie · Advanced Circulatory Systems, Inc. · R44 · FY2007 · HL
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
$1,014,729Bradley T. Keller · Accuronix Therapeutics, Inc. · R42 · FY2021 · CA